1. Home
  2. STVN vs CHH Comparison

STVN vs CHH Comparison

Compare STVN & CHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • CHH
  • Stock Information
  • Founded
  • STVN 1949
  • CHH 1939
  • Country
  • STVN Italy
  • CHH United States
  • Employees
  • STVN N/A
  • CHH N/A
  • Industry
  • STVN Containers/Packaging
  • CHH Hotels/Resorts
  • Sector
  • STVN Consumer Discretionary
  • CHH Consumer Discretionary
  • Exchange
  • STVN Nasdaq
  • CHH Nasdaq
  • Market Cap
  • STVN 6.2B
  • CHH 6.8B
  • IPO Year
  • STVN 2021
  • CHH 1997
  • Fundamental
  • Price
  • STVN $19.02
  • CHH $146.24
  • Analyst Decision
  • STVN Buy
  • CHH Hold
  • Analyst Count
  • STVN 3
  • CHH 11
  • Target Price
  • STVN $29.33
  • CHH $129.00
  • AVG Volume (30 Days)
  • STVN 633.0K
  • CHH 419.9K
  • Earning Date
  • STVN 11-05-2024
  • CHH 11-04-2024
  • Dividend Yield
  • STVN 0.31%
  • CHH 0.79%
  • EPS Growth
  • STVN N/A
  • CHH N/A
  • EPS
  • STVN 0.48
  • CHH 5.17
  • Revenue
  • STVN $1,220,254,294.00
  • CHH $779,010,000.00
  • Revenue This Year
  • STVN $3.01
  • CHH $109.47
  • Revenue Next Year
  • STVN $7.78
  • CHH $3.20
  • P/E Ratio
  • STVN $39.99
  • CHH $28.27
  • Revenue Growth
  • STVN 3.53
  • CHH 3.06
  • 52 Week Low
  • STVN $16.56
  • CHH $108.91
  • 52 Week High
  • STVN $34.73
  • CHH $149.75
  • Technical
  • Relative Strength Index (RSI)
  • STVN 43.43
  • CHH 68.05
  • Support Level
  • STVN $17.12
  • CHH $142.04
  • Resistance Level
  • STVN $22.07
  • CHH $147.42
  • Average True Range (ATR)
  • STVN 1.37
  • CHH 3.46
  • MACD
  • STVN -0.05
  • CHH 0.10
  • Stochastic Oscillator
  • STVN 21.48
  • CHH 70.54

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About CHH Choice Hotels International Inc.

As of Dec. 31, 2023, Choice Hotels operated 633,000 rooms across 15 brands addressing the economy and midscale segments. Comfort Inn and Comfort Suites are the largest brands (27% of the company's total domestic rooms), while Ascend and Cambria (7% of total domestic rooms) are newer lifestyle and select-service brands. Choice closed on its Radisson acquisition in August 2022, which added around 70,000 rooms. Franchises account for 100% of total revenue, and the United States represent 79% of total rooms in 2023.

Share on Social Networks: